701 related articles for article (PubMed ID: 21332731)
1. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors.
Seo DH; Whang DH; Song EY; Kim HS; Park Q
Transfusion; 2011 Aug; 51(8):1840-6. PubMed ID: 21332731
[TBL] [Abstract][Full Text] [Related]
2. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
3. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
[TBL] [Abstract][Full Text] [Related]
4. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
5. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
Katz L; Strong DM; Tegtmeier G; Stramer S
Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
[TBL] [Abstract][Full Text] [Related]
6. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
[TBL] [Abstract][Full Text] [Related]
7. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran.
Sofian M; Aghakhani A; Izadi N; Banifazl M; Kalantar E; Eslamifar A; Ramezani A
Int J Infect Dis; 2010 Apr; 14(4):e308-10. PubMed ID: 19656713
[TBL] [Abstract][Full Text] [Related]
8. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil.
Silva CM; Costi C; Costa C; Michelon C; Oravec R; Ramos AB; Niel C; Rossetti ML
J Infect; 2005 Jul; 51(1):24-9. PubMed ID: 15979486
[TBL] [Abstract][Full Text] [Related]
9. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of occult hepatitis B virus infection in a general adult population in Korea.
Song EY; Yun YM; Park MH; Seo DH
Intervirology; 2009; 52(2):57-62. PubMed ID: 19401629
[TBL] [Abstract][Full Text] [Related]
11. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
[TBL] [Abstract][Full Text] [Related]
12. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay.
O'Brien SF; Yi QL; Fan W; Fearon MA; Scalia V; Goldman M
Transfusion; 2009 Feb; 49(2):271-7. PubMed ID: 19389210
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
Kleinman SH; Strong DM; Tegtmeier GG; Holland PV; Gorlin JB; Cousins C; Chiacchierini RP; Pietrelli LA
Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
[TBL] [Abstract][Full Text] [Related]
16. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission.
El-Zayadi AR; Ibrahim EH; Badran HM; Saeid A; Moneib NA; Shemis MA; Abdel-Sattar RM; Ahmady AM; El-Nakeeb A
Transfus Med; 2008 Feb; 18(1):55-61. PubMed ID: 18279193
[TBL] [Abstract][Full Text] [Related]
17. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors.
Muselmani W; Habbal W; Monem F
Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of "anti-HBc alone" and HBV DNA detection among anti-HBc alone in Korea.
Kang SY; Kim MH; Lee WI
J Med Virol; 2010 Sep; 82(9):1508-14. PubMed ID: 20648604
[TBL] [Abstract][Full Text] [Related]
19. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
20. Donor screening for hepatitis B virus infection in a cell and tissue bank.
Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
